Cargando…
Evaluation of complete response to azacitidine according to the revised International Working Group 2023 response criteria for higher risk MDS. Does it make a difference in patients’ outcome?
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681887/ https://www.ncbi.nlm.nih.gov/pubmed/37816955 http://dx.doi.org/10.1038/s41375-023-02051-3 |
| _version_ | 1785150854513295360 |
|---|---|
| author | Bouchla, Anthi Papageorgiou, Sotirios G. Symeonidis, Argyris Sakellari, Ioanna Zikos, Panagiotis Thomopoulos, Thomas P. Hatzimichael, Eleftheria Galanopoulos, Athanasios Vyniou, Nora-Athina Kotsianidis, Ioannis Pappa, Vasiliki |
| author_facet | Bouchla, Anthi Papageorgiou, Sotirios G. Symeonidis, Argyris Sakellari, Ioanna Zikos, Panagiotis Thomopoulos, Thomas P. Hatzimichael, Eleftheria Galanopoulos, Athanasios Vyniou, Nora-Athina Kotsianidis, Ioannis Pappa, Vasiliki |
| author_sort | Bouchla, Anthi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10681887 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106818872023-11-30 Evaluation of complete response to azacitidine according to the revised International Working Group 2023 response criteria for higher risk MDS. Does it make a difference in patients’ outcome? Bouchla, Anthi Papageorgiou, Sotirios G. Symeonidis, Argyris Sakellari, Ioanna Zikos, Panagiotis Thomopoulos, Thomas P. Hatzimichael, Eleftheria Galanopoulos, Athanasios Vyniou, Nora-Athina Kotsianidis, Ioannis Pappa, Vasiliki Leukemia Letter Nature Publishing Group UK 2023-10-10 2023 /pmc/articles/PMC10681887/ /pubmed/37816955 http://dx.doi.org/10.1038/s41375-023-02051-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Bouchla, Anthi Papageorgiou, Sotirios G. Symeonidis, Argyris Sakellari, Ioanna Zikos, Panagiotis Thomopoulos, Thomas P. Hatzimichael, Eleftheria Galanopoulos, Athanasios Vyniou, Nora-Athina Kotsianidis, Ioannis Pappa, Vasiliki Evaluation of complete response to azacitidine according to the revised International Working Group 2023 response criteria for higher risk MDS. Does it make a difference in patients’ outcome? |
| title | Evaluation of complete response to azacitidine according to the revised International Working Group 2023 response criteria for higher risk MDS. Does it make a difference in patients’ outcome? |
| title_full | Evaluation of complete response to azacitidine according to the revised International Working Group 2023 response criteria for higher risk MDS. Does it make a difference in patients’ outcome? |
| title_fullStr | Evaluation of complete response to azacitidine according to the revised International Working Group 2023 response criteria for higher risk MDS. Does it make a difference in patients’ outcome? |
| title_full_unstemmed | Evaluation of complete response to azacitidine according to the revised International Working Group 2023 response criteria for higher risk MDS. Does it make a difference in patients’ outcome? |
| title_short | Evaluation of complete response to azacitidine according to the revised International Working Group 2023 response criteria for higher risk MDS. Does it make a difference in patients’ outcome? |
| title_sort | evaluation of complete response to azacitidine according to the revised international working group 2023 response criteria for higher risk mds. does it make a difference in patients’ outcome? |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681887/ https://www.ncbi.nlm.nih.gov/pubmed/37816955 http://dx.doi.org/10.1038/s41375-023-02051-3 |
| work_keys_str_mv | AT bouchlaanthi evaluationofcompleteresponsetoazacitidineaccordingtotherevisedinternationalworkinggroup2023responsecriteriaforhigherriskmdsdoesitmakeadifferenceinpatientsoutcome AT papageorgiousotiriosg evaluationofcompleteresponsetoazacitidineaccordingtotherevisedinternationalworkinggroup2023responsecriteriaforhigherriskmdsdoesitmakeadifferenceinpatientsoutcome AT symeonidisargyris evaluationofcompleteresponsetoazacitidineaccordingtotherevisedinternationalworkinggroup2023responsecriteriaforhigherriskmdsdoesitmakeadifferenceinpatientsoutcome AT sakellariioanna evaluationofcompleteresponsetoazacitidineaccordingtotherevisedinternationalworkinggroup2023responsecriteriaforhigherriskmdsdoesitmakeadifferenceinpatientsoutcome AT zikospanagiotis evaluationofcompleteresponsetoazacitidineaccordingtotherevisedinternationalworkinggroup2023responsecriteriaforhigherriskmdsdoesitmakeadifferenceinpatientsoutcome AT thomopoulosthomasp evaluationofcompleteresponsetoazacitidineaccordingtotherevisedinternationalworkinggroup2023responsecriteriaforhigherriskmdsdoesitmakeadifferenceinpatientsoutcome AT hatzimichaeleleftheria evaluationofcompleteresponsetoazacitidineaccordingtotherevisedinternationalworkinggroup2023responsecriteriaforhigherriskmdsdoesitmakeadifferenceinpatientsoutcome AT galanopoulosathanasios evaluationofcompleteresponsetoazacitidineaccordingtotherevisedinternationalworkinggroup2023responsecriteriaforhigherriskmdsdoesitmakeadifferenceinpatientsoutcome AT vyniounoraathina evaluationofcompleteresponsetoazacitidineaccordingtotherevisedinternationalworkinggroup2023responsecriteriaforhigherriskmdsdoesitmakeadifferenceinpatientsoutcome AT kotsianidisioannis evaluationofcompleteresponsetoazacitidineaccordingtotherevisedinternationalworkinggroup2023responsecriteriaforhigherriskmdsdoesitmakeadifferenceinpatientsoutcome AT pappavasiliki evaluationofcompleteresponsetoazacitidineaccordingtotherevisedinternationalworkinggroup2023responsecriteriaforhigherriskmdsdoesitmakeadifferenceinpatientsoutcome |